{
    "xml": "<topic id=\"PHP3806\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/indinavir\" basename=\"indinavir\" title=\"INDINAVIR\">\n<title>INDINAVIR</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_398\" namespace=\"/interactions/list-of-drug-interactions/antivirals/indinavir\">Indinavir</xref>\n</p>\n<data name=\"vtmid\">108695003</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_643762552\" title=\"Protease inhibitors (HIV)\">Protease inhibitors (HIV)</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34642\" title=\"PROTEASE INHIBITORS\" namespace=\"/drug-classes/protease-inhibitors\">PROTEASE INHIBITORS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP43879\" outputclass=\"indicationsAndDose\" rev=\"1.19\" parent=\"/drugs/indinavir\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">HIV infection in combination with nucleoside reverse transcriptase inhibitors</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Seek specialist advice.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43923\" outputclass=\"cautions\" rev=\"1.7\" parent=\"/drugs/indinavir\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Ensure adequate hydration (risk of nephrolithiasis)</ph>; <ph outputclass=\"caution\">patients at high risk of cardiovascular disease (especially if 10-year cardiovascular risk greater than 20%)</ph>; <ph outputclass=\"caution\">patients at risk of nephrolithiasis (monitor for nephrolithiasis)</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43878\" outputclass=\"interactions\" rev=\"1.7\" parent=\"/drugs/indinavir\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (indinavir).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43860\" outputclass=\"sideEffects\" rev=\"1.8\" parent=\"/drugs/indinavir\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Alopecia</ph>; <ph outputclass=\"sideEffect\">crystalluria</ph>; <ph outputclass=\"sideEffect\">dry mouth</ph>; <ph outputclass=\"sideEffect\">dry skin</ph>; <ph outputclass=\"sideEffect\">dysuria</ph>; <ph outputclass=\"sideEffect\">haematuria</ph>; <ph outputclass=\"sideEffect\">haemolytic anaemia</ph>; <ph outputclass=\"sideEffect\">hyperpigmentation</ph>; <ph outputclass=\"sideEffect\">hypoaesthesia</ph>; <ph outputclass=\"sideEffect\">interstitial nephritis (with medullary calcification and cortical atrophy in asymptomatic severe leucocyturia)</ph>; <ph outputclass=\"sideEffect\">nephrolithiasis (may require interruption or discontinuation)</ph>; <ph outputclass=\"sideEffect\">paronychia</ph>; <ph outputclass=\"sideEffect\">proteinuria</ph>; <ph outputclass=\"sideEffect\">pyelonephritis</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43876\" outputclass=\"pregnancy\" parent=\"/drugs/indinavir\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Toxicity in <i>animal</i> studies; manufacturer advises use only if potential benefit outweighs risk; theoretical risk of hyperbilirubinaemia and renal stones in neonate if used at term.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43882\" outputclass=\"hepaticImpairment\" parent=\"/drugs/indinavir\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Reduce dose in mild to moderate impairment.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Not studied in severe impairment.</p>\n<p>Increased risk of nephrolithiasis.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43870\" outputclass=\"renalImpairment\" parent=\"/drugs/indinavir\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"additionalMonitoringInRenalImpairment\">\n<sectiondiv>\n<p>In patients with renal impairment, monitor for nephrolithiasis.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43954\" outputclass=\"directionsForAdministration\" rev=\"1.9\" parent=\"/drugs/indinavir\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>Administer 1 hour before or 2 hours after a meal; may be administered with a low-fat light meal; in combination with didanosine tablets, allow 1 hour between each drug (antacids in didanosine tablets reduce absorption of indinavir); in combination with low-dose ritonavir, give with food.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58620\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.9\" parent=\"/drugs/indinavir\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Dispense in original container (contains desiccant).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43871\" outputclass=\"patientAndCarerAdvice\" rev=\"1.9\" parent=\"/drugs/indinavir\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patients or carers should be given advice on how to administer indinavir capsules.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43837\" outputclass=\"lessSuitableForPrescribing\" rev=\"1.11\" parent=\"/drugs/indinavir\">\n<title>Less suitable for prescribing</title>\n<body>\n<section>\n<sectiondiv>\n<p>Indinavir is rarely used in the treatment of HIV-infection because it is associated with nephrolithiasis; it is considered to be less suitable for prescribing.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP3806-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/indinavir\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77007\" title=\"Capsule\" namespace=\"/drugs/indinavir/capsule\">Capsule</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78275\" namespace=\"/treatment-summaries/hiv-infection\" title=\"HIV infection\" count=\"3\" rel=\"backlink\">HIV infection</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_398\" namespace=\"/interactions/list-of-drug-interactions/antivirals/indinavir\" title=\"Indinavir\" count=\"1\" rel=\"link\">Indinavir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34642\" namespace=\"/drug-classes/protease-inhibitors\" title=\"PROTEASE INHIBITORS\" count=\"1\" rel=\"link\">PROTEASE INHIBITORS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77007\" namespace=\"/drugs/indinavir/capsule\" title=\"Capsule\" count=\"1\" rel=\"link\">Capsule</xref>\n</links>\n</topic>",
    "id": "PHP3806",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/indinavir",
    "basename": "indinavir",
    "title": "INDINAVIR",
    "interactants": [
        {
            "id": "bnf_int_398",
            "label": "Indinavir"
        }
    ],
    "vtmid": "108695003",
    "drugClassification": [
        "Protease inhibitors (HIV)"
    ],
    "inheritsFromClass": [
        "PROTEASE INHIBITORS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "HIV infection in combination with nucleoside reverse transcriptase inhibitors",
                        "html": "HIV infection in combination with nucleoside reverse transcriptase inhibitors"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Seek specialist advice.",
                        "html": "<p>Seek specialist advice.</p>"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Ensure adequate hydration (risk of nephrolithiasis)",
                "html": "Ensure adequate hydration (risk of nephrolithiasis)"
            },
            {
                "type": "cautions",
                "textContent": "patients at high risk of cardiovascular disease (especially if 10-year cardiovascular risk greater than 20%)",
                "html": "patients at high risk of cardiovascular disease (especially if 10-year cardiovascular risk greater than 20%)"
            },
            {
                "type": "cautions",
                "textContent": "patients at risk of nephrolithiasis (monitor for nephrolithiasis)",
                "html": "patients at risk of nephrolithiasis (monitor for nephrolithiasis)"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (indinavir).",
                "html": "<p>Appendix 1 (indinavir).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Alopecia",
                        "html": "Alopecia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "crystalluria",
                        "html": "crystalluria",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dry mouth",
                        "html": "dry mouth",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dry skin",
                        "html": "dry skin",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dysuria",
                        "html": "dysuria",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "haematuria",
                        "html": "haematuria",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "haemolytic anaemia",
                        "html": "haemolytic anaemia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hyperpigmentation",
                        "html": "hyperpigmentation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypoaesthesia",
                        "html": "hypoaesthesia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "interstitial nephritis (with medullary calcification and cortical atrophy in asymptomatic severe leucocyturia)",
                        "html": "interstitial nephritis (with medullary calcification and cortical atrophy in asymptomatic severe leucocyturia)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nephrolithiasis (may require interruption or discontinuation)",
                        "html": "nephrolithiasis (may require interruption or discontinuation)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "paronychia",
                        "html": "paronychia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "proteinuria",
                        "html": "proteinuria",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pyelonephritis",
                        "html": "pyelonephritis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Toxicity in animal studies; manufacturer advises use only if potential benefit outweighs risk; theoretical risk of hyperbilirubinaemia and renal stones in neonate if used at term.",
                "html": "<p>Toxicity in <i>animal</i> studies; manufacturer advises use only if potential benefit outweighs risk; theoretical risk of hyperbilirubinaemia and renal stones in neonate if used at term.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Reduce dose in mild to moderate impairment.",
                "html": "<p>Reduce dose in mild to moderate impairment.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Not studied in severe impairment.\n\nIncreased risk of nephrolithiasis.",
                "html": "<p>Not studied in severe impairment.</p><p>Increased risk of nephrolithiasis.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution.",
                "html": "<p>Use with caution.</p>"
            }
        ],
        "additionalMonitoring": [
            {
                "type": "additionalMonitoring",
                "textContent": "In patients with renal impairment, monitor for nephrolithiasis.",
                "html": "<p>In patients with renal impairment, monitor for nephrolithiasis.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Administer 1 hour before or 2 hours after a meal; may be administered with a low-fat light meal; in combination with didanosine tablets, allow 1 hour between each drug (antacids in didanosine tablets reduce absorption of indinavir); in combination with low-dose ritonavir, give with food.",
                "html": "<p>Administer 1 hour before or 2 hours after a meal; may be administered with a low-fat light meal; in combination with didanosine tablets, allow 1 hour between each drug (antacids in didanosine tablets reduce absorption of indinavir); in combination with low-dose ritonavir, give with food.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Dispense in original container (contains desiccant).",
                "html": "<p>Dispense in original container (contains desiccant).</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patients or carers should be given advice on how to administer indinavir capsules.",
                "html": "<p>Patients or carers should be given advice on how to administer indinavir capsules.</p>"
            }
        ]
    },
    "lessSuitableForPrescribing": {
        "lessSuitableForPrescribing": [
            {
                "type": "lessSuitableForPrescribing",
                "textContent": "Indinavir is rarely used in the treatment of HIV-infection because it is associated with nephrolithiasis; it is considered to be less suitable for prescribing.",
                "html": "<p>Indinavir is rarely used in the treatment of HIV-infection because it is associated with nephrolithiasis; it is considered to be less suitable for prescribing.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77007",
                "label": "Capsule",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78275",
                "label": "HIV infection",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_398",
                "label": "Indinavir",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34642",
                "label": "PROTEASE INHIBITORS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77007",
                "label": "Capsule",
                "type": "medicinalForm"
            }
        ]
    }
}